IgG2 from Normal Human Plasma: Preparation & Use Protocol

Immunoglobulin G2 (IgG2) from Normal Human Plasma is a highly purified human IgG subclass protein sourced from FDA-licensed collection centers and prepared in strict compliance with current FDA donor screening and viral testing regulations, making it a reliable reference standard and isotype control for immunological research.

Product Name

Immunoglobulin G2 (IgG2) from Normal Human Plasma

Athens Source Reference

16-16-090707-2

Source Material

Normal human plasma collected from FDA-licensed blood collection centers

Regulatory Compliance

Donor screening and viral testing performed per current FDA regulations

IgG Subclass

IgG2 (one of four human IgG subclasses)

SKU

np001060

Product Overview and Background

Immunoglobulin G2 (IgG2) is one of the four subclasses of human IgG (IgG1, IgG2, IgG3, and IgG4). IgG2 constitutes approximately 20–25% of total serum IgG in healthy adults and is characterized by its restricted hinge region, which confers structural rigidity and influences its effector functions. IgG2 antibodies are most prominently elicited in response to thymus-independent polysaccharide antigens, making them particularly relevant in studies of antibacterial immunity and vaccine development.

This product (SKU: np001060; Athens reference 16-16-090707-2) is purified from pooled normal human plasma collected exclusively at FDA-licensed blood collection centers. All source plasma undergoes rigorous donor screening and viral testing in accordance with current U.S. FDA regulations, ensuring a high level of safety and consistency suitable for research use.

Materials and Equipment Required

Before beginning any experiment using IgG2 from Normal Human Plasma, ensure that the following materials and equipment are available:

• IgG2 from Normal Human Plasma (np001060, Aladdin Scientific)
• Sterile phosphate-buffered saline (PBS, pH 7.4) for reconstitution and dilution
• Microcentrifuge tubes (1.5 mL or 2.0 mL, low-protein-binding recommended)
• Calibrated micropipettes and sterile tips
• Refrigerated microcentrifuge
• UV-Vis spectrophotometer or BCA/Bradford protein assay kit for concentration verification
• SDS-PAGE gel system and Western blotting apparatus (if purity verification is required)
• Appropriate secondary detection reagents (e.g., anti-human IgG HRP conjugate) for downstream assays
• Personal protective equipment (PPE): lab coat, gloves, eye protection

All human-derived materials should be handled as potentially infectious in accordance with institutional biosafety guidelines.

Step-by-Step Protocol

Step 1 – Reconstitution (if lyophilized)
Allow the vial to equilibrate to room temperature for 10–15 minutes before opening. Reconstitute the lyophilized protein in the volume of sterile ultrapure water or PBS (pH 7.4) specified on the product datasheet. Mix gently by slow inversion or pipetting; do not vortex, as this may cause protein aggregation or denaturation. Allow 5–10 minutes for complete dissolution.

Step 2 – Concentration Verification
Measure protein concentration using a UV absorbance reading at 280 nm (using the extinction coefficient provided in the datasheet) or by a colorimetric assay (BCA or Bradford). Compare the measured value to the stated lot concentration to confirm integrity upon receipt.

Step 3 – Aliquoting and Storage
Prepare single-use aliquots to minimize freeze-thaw cycles, which can reduce protein integrity. Store aliquots at –20 °C for short-term use or –80 °C for long-term storage. Avoid repeated freeze-thaw cycles (recommended maximum: ≤3 cycles). Do not store in a frost-free freezer.

Step 4 – Working Dilution Preparation
Dilute the stock to the working concentration required for your specific application (e.g., ELISA, flow cytometry, Western blot, isotype control) using sterile PBS or the assay-appropriate buffer. For isotype control applications, match the concentration precisely to the experimental antibody concentration.

Step 5 – Quality Check Before Use
Inspect the solution for visible aggregates or turbidity before each use. If aggregation is suspected, briefly centrifuge at 10,000 × g for 5 minutes at 4 °C and use only the clear supernatant.

Applications and Assay Guidance

IgG2 from Normal Human Plasma is suitable for a variety of immunological research applications, including but not limited to:

• Isotype Control: Use as a negative isotype control in flow cytometry, immunohistochemistry (IHC), immunofluorescence (IF), and ELISA to distinguish specific antibody binding from non-specific background.
• Immunoassay Calibration and Standardization: Serve as a reference standard to establish quantitative curves for IgG2-specific ELISA or nephelometry-based assays.
• Structural and Biophysical Studies: Suitable for studies investigating IgG subclass-specific hinge region flexibility, glycosylation patterns, and Fc receptor interaction.
• Complement Activation Studies: IgG2 exhibits limited classical complement pathway activation compared to IgG1 and IgG3; this product can be used in comparative studies of subclass effector functions.
• Vaccine Research: Useful as a reference protein in studies examining polysaccharide antigen-induced humoral immune responses.

Optimal concentrations and assay conditions should be determined empirically for each specific application and instrument platform.

Safety, Storage, and Regulatory Notes

Biosafety: This product is derived from normal human plasma. Although donor screening and viral testing are performed in accordance with current FDA regulations, no testing method can guarantee complete absence of all infectious agents. Handle all human-derived materials at a minimum under Biosafety Level 2 (BSL-2) conditions, following your institution's biosafety policies and applicable local regulations.

Storage Conditions: Store as directed on the product datasheet. Typical storage conditions for purified immunoglobulins involve –20 °C to –80 °C. Avoid repeated freeze-thaw cycles. Working solutions may be stored at 2–8 °C for short durations (typically ≤1 week); verify stability under specific assay buffer conditions.

Regulatory Statement: Source plasma is collected from FDA-licensed blood collection centers, and the supplier conducts donor screening and viral testing per current FDA requirements. This product is for research use only (RUO) and is not intended for diagnostic, therapeutic, or clinical use in humans or animals.

Disposal: Dispose of all human-derived biological materials in accordance with institutional, local, and national biohazardous waste disposal regulations.

Frequently asked questions

What is the source and regulatory compliance of this IgG2 product?

This IgG2 (np001060; Athens reference 16-16-090707-2) is purified from normal human plasma collected exclusively at U.S. FDA-licensed blood collection centers. The supplier performs donor screening and viral testing in strict accordance with current FDA regulations, providing a high standard of quality and traceability for research applications.

Can IgG2 from Normal Human Plasma be used as an isotype control in flow cytometry?

Yes. Human IgG2 is commonly used as a negative isotype control in flow cytometry, IHC, IF, and ELISA experiments. When used as an isotype control, it is critical to match the concentration of the IgG2 control precisely to that of the primary antibody of interest to ensure valid comparison of non-specific background signal.

How should IgG2 from Normal Human Plasma be stored to maintain protein integrity?

The product should be stored according to the conditions specified on the product datasheet, typically at –20 °C for short-term or –80 °C for long-term storage. To preserve protein integrity, prepare single-use aliquots to avoid repeated freeze-thaw cycles, which can lead to aggregation and activity loss. Working solutions prepared in PBS should be used promptly or stored at 2–8 °C for no longer than one week.

Is this product safe to handle in a standard laboratory setting?

All human plasma-derived materials carry an inherent, though regulated, biohazard risk. While this product is manufactured from plasma that has undergone FDA-compliant donor screening and viral testing, it should be treated as potentially infectious. Handle under BSL-2 conditions at minimum, wearing appropriate PPE (lab coat, gloves, eye protection), and dispose of waste in compliance with institutional and regulatory biohazard waste guidelines.

What distinguishes IgG2 from other IgG subclasses in immunological research?

IgG2 is characterized by a short, rigid hinge region that restricts flexibility between the Fab and Fc domains, which affects its ability to activate complement and interact with Fc receptors. Unlike IgG1 and IgG3, IgG2 shows limited classical complement pathway activation. Functionally, IgG2 antibodies are predominantly induced by thymus-independent polysaccharide antigens, making IgG2 particularly important in the study of anti-capsular antibody responses and pneumococcal or meningococcal vaccine immunogenicity.

References

1. Jefferis R, Kumararatne DS. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol. 1990;81(3):357-367.
2. Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520.
3. Schur PH. IgG subclasses: a review. Ann Allergy. 1987;58(2):89-96, 99.
4. Athens Research & Technology. Product Reference 16-16-090707-2: Immunoglobulin G2 (IgG2) from Normal Human Plasma. Supplier documentation.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.